Ledger.Open graph →
SEC Form D · filed September 23, 2025

Mati Therapeutics Inc

Offering
$2.2M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AUSTIN, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Joseph Tortorice Iii · Austin, TXDirectorCameron Nelson · Austin, TXExecChristopher Muller · Austin, TXExec · DirectorRobert Butchofsky · Austin, TXExec · DirectorDeepank Utkhede · Austin, TXDirectorRobert Butchofsky · Austin, TXExec · DirectorCameron Nelson · Austin, TXExecJoseph Tortorice Iii · Austin, TXDirectorChristopher Muller · Austin, TXExec · DirectorDeepank Utkhede · Austin, TXDirectorErica Albrecht · New York, NYDirectorAdam Sachs · New York, NYExecW. D. Aylesworth · Calgary, Alberta, CanadaExec · DirectorMax Junestrand · Dover, DEDirectorSigge Labor · Dover, DEExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗